The scientists, led by Joseph Vinetz, MD, an infectious diseases specialist, were interested to find out if an oral medication used to treat pancreatitis could reduce the viral load (the amount of virus in your body) of SARS-CoV-2 and improve symptoms in people newly diagnosed wi... Read More >

The Biden-Harris Administration announced on April 4 that more than 59 million Americans with Medicare Part B, including those enrolled in a Medicare Advantage plan, now have access to Food and Drug Administration (FDA) approved, authorized, or cleared OTC COVID-19 tests at no co... Read More >

SeekIn said on Thursday that it has received CE marking for its LeukoPrint Molecular Karyotyping Kit for the diagnosis and stratification of leukemia patients.... Read More >

The body’s ability to respond to various types of stress is essential for maintaining health, and failure of such adaptive stress responses can trigger or worsen numerous diseases. ... Read More >

On April 6, it was reported that the Rapid SARS-CoV-2 Antigen Test Card produced by Xiamen Boson Biotech Co., Ltd. has obtained the FDA Emergency Use Authorization (EUA). ... Read More >

Seegene said on Wednesday that it has received Australian approval and CE-IVD marking for its Allplex RV Master Assay for respiratory viruses.... Read More >

April 5, 2022 – GE Healthcare and Elekta (EKTA-B.ST) announced today that they have signed a global commercial collaboration agreement in the field of radiation oncology.... Read More >

On 28 March, Sanxing Medical Electric Co., Ltd. (601566.SH), made several announcements announcing that its subsidiary, Rehabilitation Investment, intended to acquire 100% of the equity interests in five hospitals for a total price of CNY 844 million. ... Read More >

UK life science tools company LGC said on Friday that it has acquired Rapid Genomics, a next-generation sequencing genotyping company based in Gainesville, Florida.... Read More >

Agilent Technologies on Tuesday announced it has obtained expanded CE-IVD marking for the use of its PD-L1 IHC 28-8 pharmDx immunohistochemical assay as a companion diagnostic test to guide treatment for newly approved indications for Bristol Myers Squibb's Opdivo.... Read More >